Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Editorial introductions72
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?61
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease60
ANGPTL4: a new mode in the regulation of intravascular lipolysis51
Alveolar macrophages: guardians of the alveolar lipid galaxy47
Sphingomyelins and ceramides: possible biomarkers for dementia?41
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism37
Genetic variation in apolipoprotein A-V in hypertriglyceridemia35
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review33
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances32
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?29
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases23
Implementation science and genetic testing for familial hypercholesterolemia18
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1918
Lipid metabolism during pregnancy: consequences for mother and child17
Oxidized LDL receptors: a recent update17
Exosomes and lipid metabolism in metabolic and cardiovascular disorders17
Familial hypercholesterolemia in children and the importance of early treatment17
Nonalcoholic fatty liver disease: an update16
A new SPRING in lipid metabolism15
Genetic determinants of pancreatitis risk in hypertriglyceridemia15
Familial hypercholesterolemia in pregnancy15
Editorial introductions15
The current state of apolipoprotein E in dyslipidemia14
From clinical development to real-world outcomes with inclisiran14
Nutrition and its impact on cardiovascular disease14
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives13
The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets13
The need for national and international registries of patients with elevated lipoprotein(a)13
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion13
Editorial introduction13
APOE and familial hypercholesterolemia12
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?12
Can small dense LDL cholesterol be estimated from the lipid profile?11
Cardiomyocytes, sphingolipids and cardio myotoxicity11
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?11
In the wake of the Scandinavian Simvastatin Survival Study trial11
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent11
Editorial introductions11
Distinct roles of size-defined HDL subpopulations in cardiovascular disease10
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis10
Strategies for management of patients with elevated lipoprotein(a)10
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease10
Newborn screening for lipid disorders10
Beyond cholesterol: linking the conformation of apolipoprotein B to atherogenesis10
Altered cardiovascular risk pattern of LDL cholesterol in older adults9
Genetic testing for familial hypercholesterolemia9
Pregnancy, cardiovascular health, and microchimerism9
Clinical associations between exercise and lipoproteins9
Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia9
0.085349082946777